Table 4 Odds ratios (ORs) for hepatocellular carcinoma (HCC) according to distribution tertiles of polychlorinated biphenyls (PCBs) in the controls.
Lipid adjusted PCB concentration in serum (ng/g lipid ) | Cases | Controls | OR (95% CI)* |
---|---|---|---|
PCB 118: | |||
T1 (0–11) | 22 | 38 | 1 |
T2 (12–21) | 10 | 32 | 0.90 (0.26–3.15) |
T3 (22–241) | 30 | 32 | 2.45 (0.85–7.07) |
PCB 138: | |||
T1 (14–67) | 21 | 34 | 1 |
T2 (68–106) | 13 | 34 | 1.44 (0.44–4.74) |
T3 (107–511) | 28 | 34 | 2.42 (0.79–7.38) |
PCB 153: | |||
T1 (23–121) | 21 | 34 | 1 |
T2 (130–196) | 12 | 34 | 1.31 (0.39–4.36) |
T3 (206–691) | 29 | 34 | 2.40 (0.79–7.31) |
PCB 156: | |||
T1 (0–15) | 28 | 35 | 1 |
T2 (16–24) | 7 | 35 | 0.29 (0.08–1.00) |
T3 (25–74) | 27 | 32 | 1.10 (0.37–3.23) |
PCB170: | |||
T1 (0–46) | 23 | 34 | 1 |
T2 (47–71) | 15 | 34 | 0.78 (0.25–2.47) |
T3 (72–209) | 24 | 34 | 1.61 (0.56–4.64) |
PCB 180: | |||
T1 (34–163) | 21 | 34 | 1 |
T2 (166–257) | 15 | 35 | 1.05 (0.32–3.48) |
T3 (261–810) | 26 | 33 | 1.69 (0.57–4.99) |
PCB 194: | |||
T1 (0–37) | 16 | 35 | 1 |
T2 (39–63) | 19 | 34 | 1.81 (0.55–5.99) |
T3 (65–231) | 27 | 33 | 4.75 (1.40–16.04) |
Total PCBs: | |||
T1 (92–556) | 24 | 34 | 1 |
T2 (569–908) | 10 | 34 | 0.61 (0.18–2.07) |
T3 (912–3089) | 28 | 34 | 1.76 (0.62–5.03) |